Effects of Magnesium on Blood Pressure in Patients with familiarity for Metabolic Syndrome - ND
- Conditions
- familiarity for matabolic syndrome
- Registration Number
- EUCTR2009-015783-34-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Healthy subjects, non suffering Hypertension, non diabetic, non obese, at the age between 18 and 50 years, with at least a relative suffering from metabolic syndrome (NCEP/ATPIII criteria).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Age below 18 and over 50, hypertension (BP≥140/90 mmHg or therapy with antihypertensive drugs), diabetes mellitus (Glycemia on empty stomach ≥126 mg/dl or therapy with antidiabetic drugs), obesity (BMI≥30 Kg/m2). Intake of hypocholesteromizant drugs, NSAIDs or other type (if continuative use). Use of magnesium supplementations or vitamin complexes. Hypermagnesemia before randomization. Previous cardiac and/or cerebrovascular events. Chronic kidney failure. Chronic inflammatory liver or renal diseases, malignant cancer, gastrointestinal dysfunctions with hypomotility. Unability to give informed consent.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method